• Study on Long-term Safety and Efficacy of Efgartigimod PH20 SC in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Bulgaria Denmark France Germany +5

  • Study on Nipocalimab for Reducing Risk of Fetal and Neonatal Alloimmune Thrombocytopenia in At-risk Pregnancies

    Recruiting

    3 1
    Investigated Drugs:
    Belgium France Germany Hungary Italy The Netherlands +5

  • Study on Reducing Bleeding Risk in Heart Attack Patients Using Clopidogrel, Ticagrelor, and Prasugrel After Stent Procedure

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark

  • Study on the Effects of Xenon and Oxygen on Brain Injury and Recovery in Patients with Aneurysmal Subarachnoid Hemorrhage in Intensive Care

    Recruiting

    2 1 1 1
    Investigated Drugs:
    Finland

  • Study on Melatonin for Patients with Uveal Melanoma to Prevent Metastasis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Sweden

  • Study on Preventing Crohn’s Disease Recurrence After Surgery Using Risankizumab and Drug Combination in Adults at Risk

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Italy

  • Study on Dexamethasone and Fluorometholone for Patients Undergoing Corneal Transplantation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany The Netherlands

  • Comparison of Furosemide, Nitrates, or Their Combination for Initial Treatment of Pulmonary Congestion in Patients with Acute Heart Failure

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark

  • Study on Immunotherapy with Nivolumab and Ipilimumab for Patients with Early Stage dMMR Rectal Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    Denmark

  • Study Comparing CPX-351 and Chemotherapy for Patients with New Intermediate or High-Risk Acute Myeloid Leukemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

powered by